The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of chimeric antigen receptor T cells modified to target mesothelin and express PD-1 antibodies in patients with relapsed/refractory solid cancers in a phase I trial.
 
Juemin Fang
No Relationships to Disclose
 
Yan Sun
Employment - Shanghai Cell Therapy Group
Stock and Other Ownership Interests - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
 
Xianling Guo
No Relationships to Disclose
 
Bailu Xie
Employment - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
 
Hui Wang
No Relationships to Disclose
 
Wei Mao
No Relationships to Disclose
 
Zhongzheng Zhu
No Relationships to Disclose
 
Zhuqing Liu
No Relationships to Disclose
 
Fei Hu
No Relationships to Disclose
 
Min Yuan
No Relationships to Disclose
 
Song Gao
No Relationships to Disclose
 
Zhicai Lin
Employment - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
 
Zhiwei Zhang
Employment - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
 
Huimei Li
Employment - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
 
Wenqi Chu
Employment - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
 
Xinru Pang
Employment - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
 
Qijun Qian
Employment - Shanghai Cell Therapy Group
Leadership - Shanghai Cell Therapy Group
Stock and Other Ownership Interests - Shanghai Cell Therapy Group
Research Funding - Shanghai Cell Therapy Group (Inst)
Patents, Royalties, Other Intellectual Property - Shanghai Cell Therapy Group
 
Huanlong Qing
No Relationships to Disclose
 
Qing Xu
No Relationships to Disclose